Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen
Clinical trial NCT03771820 · UNKNOWN
Trial details
- NCT number
- NCT03771820
- Sponsor
- NanoCarrier Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2021-04-30
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.